ABSTRACT One hundred patients with tracheobronchial tumours were treated with the neodymium YAG (yttrium-aluminium-garnet) or If clearance of the airways was considered inadequate at the first attempt, we were prepared to give up to three sessions of laser treatment during the initial admission to hospital, after which no further treatment was attempted if the patient did not improve. Follow up treatments were given at one to three month intervals, depending on the speed with which symptoms recurred, for as long as further response was seen and breathlessness or haemoptysis remained predominant symptoms.
We have previously reported our early experience with the neodymium yttrium-aluminium-garnet (Nd-YAG) and argon lasers in the palliative treatment of advanced tracheobronchial tumours.' Other authors have described similar series2-4 This paper describes results for our first 100 cases, with particular reference to improvements in technique and the relative merits of treatment under local and general anaesthesia.
Patients and methods
Patients were recruited who had histologically proved and inoperable tracheal or bronchial tumours which were causing symptoms of breathlessness or recurrent haemoptysis. Previous attempts at palliation with radiotherapy or chemotherapy either had failed or symptoms had recurred after an earlier response. In some cases laser was the first attempt at treatment because patients were considered unfit for conventional treatment or had refused it. They were given laser treatment if at bronchoscopy our initiar impression was that symptoms were mainly attributable to intraluminal tumour which was accessible to the bronchoscope; in most cases, however, there was also extrinsic compression of the airway, presumably due to tumour outside the bronchial wall. Although many patients had metastases, symptoms were mainly attributable to local disease at the primary site.
If clearance of the airways was considered inadequate at the first attempt, we were prepared to give up to three sessions of laser treatment during the initial admission to hospital, after which no further treatment was attempted if the patient did not improve. Follow up treatments were given at one to three month intervals, depending on the speed with which symptoms recurred, for as long as further response was seen and breathlessness or haemoptysis remained predominant symptoms.
Response to treatment was assessed by the patients' account of their symptoms and by the results of pulmonary function tests, which included peak expiratory flow rate, spirometric values, and a flow-volume loop. Exercise tolerance was measured by the six minute walking test.5 Full pulmonary function testing was not completed in a few of our early patients and could not be performed in some patients because of extreme breathlessness, but peak flow rate was always attempted on the ward with a Wright peak flow meter. These tests were performed before and after treatment and repeated at outpatient sessions and before subsequent treatments. A symptomatic improvement was recorded if the patient said that he or she felt better and if there was an improvement in the six minute walk. Objective improvement was recorded if there was a grea-341
Hetzel, Nixon, Edmondstone, Mitchell, Millard, Nanson, Woodcock, Bridges, Humberstone ter than 25% rise in peak flow rate, since this information was consistently available. Such cases usually showed improvement in spirometric indices and flow-volume loops as well. In patients with an unrecordable peak flow 601 min-' was taken as the starting point for this calculation.
In patients treated for haemoptysis diary charts were recorded from the time of admission for assessment for laser treatment. After discharge home records were continued by the patient, who was asked to record each day whether blood had been coughed up orifice of the remaining right bronchus. We were unable to record her peak flow rate at the time of her referral to us. In the opinion of the anaesthetist (CN) the risk of general anaesthesia was unacceptably high. The risks of laser treatment were obviously considerable in these two patients but were considered justified by the lack of alternative treatment, the patients' distress from their severe stridor, and their determination to be treated rather than suffer their symptoms further. The only other sequela of treatment was the occasional need to remove viscid exudate after treatment by follow up bronchoscopy. This has not yet been necessary after rigid bronchoscopy, probably because more effective clearance of the airway was possible at a single treatment. One patient treated with rigid bronchoscopy and jet ventilation developed a pneumothorax which required intercostal drainage. Otherwise treatment was well tolerated, with full recovery usually evident within 24 hours.
SURVIVAL
The figure shows the cumulative survival curve for the 100 patients recruited. Sixty eight showed at least symptomatic benefit from laser phototherapy and were given further treatments on relapse, and there were 32 non-responders, who had no evidence of palliative benefit and who were not treated again.
No control group of similar patients not treated with the laser is available for analysis of the effect of laser phototherapy on survival.
Discussion
This larger series, with improvements in our technical expertise, confirms our earlier view' that, in patients with predominantly intraluminal tumours, laser phototherapy is a valuable palliative treatment that may be effective when radiotherapy or chemotherapy have failed. It has advantages of immediate response, no systemic toxicity, and no dosage limit. It is most effective when used for clearing partial obstruction due to tumours in the trachea or at the carina. For haemoptysis results were encouraging, provided that the site of bleeding could be identified. In our hands an overall mortality of 2% was acceptable in these-patients-with advanced tumours and poor respiratory function. Reexpansion of collapsed lungs is technically more difficult. There are no anatomical landmarks to ensure the correct line of cut through the completely obstructing tumour. It is also impossible to assess the extent of tumour or viability of the lung once collapse has occurred. Risk of pneumonia is probably increased if only a small airway can be established. Attempts should be made to clear the bronchus thoroughly and vigorous physiotherapy and prophylactic antibiotic treatment are obvious precautions.
Our assessment of these cases was limited to simple spirometry and exercise tests. Laser phototherapy may have improved ventilation only to the re-expanded lung; we have no information about its effects on perfusion. More complex tests-for example, ventilation-perfusion lung scanningmight have been useful in these cases and further studies are in progress.
The Nd YAG laser penetrates more deeply than the argon laser, achieving greater tumour destruction, and we now use it exclusively. The fibreoptic 
